Literature DB >> 3800535

Consistency of sequential needle biopsy findings for thyroid nodules. Management implications.

J I Hamburger.   

Abstract

Needle biopsy can reduce unnecessary surgery for thyroid nodules. However, needle biopsy diagnoses of "benign" may be erroneous. Thyroxine may produce regression in such nodules, but usually does not. Some authorities advise surgery for nonresponding nodules; others rely on repeat needle biopsy. In 246 patients, diagnoses by repeat needle biopsy confirmed 85% of the original diagnoses by needle biopsy. Initial benign diagnoses by needle biopsy were confirmed for 187 (91%) of 205 patients. Fourteen had surgery; all nodules were benign. Changes in diagnosis from benign to suspicious by needle biopsy were made for 12 patients; five had surgery, one had a Hürthle cell carcinoma. Changes in diagnosis from benign to malignant by needle biopsy were made in six patients; five had surgery, all lesions were malignant. Reliance on repeat needle biopsy is preferable to routine surgery for nodules not responding to thyroxine.

Entities:  

Mesh:

Year:  1987        PMID: 3800535

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

1.  How to manage thyroid nodules with two consecutive non-diagnostic results on ultrasonography-guided fine-needle aspiration.

Authors:  Hee Jung Moon; Jin Young Kwak; Yoon Seong Choi; Eun-Kyung Kim
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Role of fine-needle aspiration biopsy and frozen section in the management of papillary thyroid carcinoma subtypes.

Authors:  Julio C Furlan; Yvan C Bedard; Irving B Rosen
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

3.  Single versus sequential fine-needle aspiration biopsy in the management of thyroid nodular disease.

Authors:  Julio C Furlan; Yvan C Bedard; Irving B Rosen
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

4.  Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions.

Authors:  Nasir A Bakshi; Ibrahim Mansoor; Bruce A Jones
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

5.  Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice.

Authors:  R V García-Mayor; L F Pérez Mendez; C Páramo; R Luna Cano; A Rego Iraeta; M Regal; J M Sierra; E Fluiters
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

6.  Fine needle aspiration cytology of thyroid nodules: conventional vs thin layer technique.

Authors:  A Cavaliere; R Colella; E Puxeddu; G Gambelunghe; N Avenia; M d'Ajello; F Cartaginese; R Vitali; G Bellezza; M Giansanti; A Sidoni; P De Feo
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

7.  Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules.

Authors:  J F Henry; A Denizot; A Porcelli; M Villafane; P Zoro; S Garcia; C De Micco
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

8.  Diagnostic accuracy of fine needle aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a systematic review and meta-analysis.

Authors:  Sarah W Lai; Derek J Roberts; Doreen M Rabi; Karin Y Winston
Journal:  Syst Rev       Date:  2015-09-24

9.  Utility of repeat cytological assessment of thyroid nodules initially classified as benign: clinical insights from multidisciplinary care in an Irish tertiary referral centre.

Authors:  Nigel Glynn; Mark J Hannon; Sarah Lewis; Patrick Hillery; Mohammed Al-Mousa; Arnold D K Hill; Frank Keeling; Martina Morrin; Christopher J Thompson; Diarmuid Smith; Derval Royston; Mary Leader; Amar Agha
Journal:  BMC Endocr Disord       Date:  2016-08-02       Impact factor: 2.763

10.  Repeat FNA Significantly Lowers Number of False Negative Results in Patients with Benign Nodular Thyroid Disease and Features of Chronic Thyroiditis.

Authors:  Dorota Słowińska-Klencka; Ewa Woźniak-Oseła; Bożena Popowicz; Stanisław Sporny; Mariusz Klencki
Journal:  Int J Endocrinol       Date:  2014-04-09       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.